focus -WSS

focus

author：leisure time 2025-09-03 03:20:13 - browse：8

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Scientific mystery highlights the blind spots in genomics databases

explore

WSS

Florida Supreme Court upholds state's abortion ban

Gut bacteria may contribute to kidney autoimmunity, study finds

Multiple sclerosis has subtypes with different best treatments: study

U.K. decision on ALS drug has neurologists, advocates up in arms

Bird flu in dairy cattle: New measures to control spread to humans

Timeline: Special counsel's investigation into Trump's handling of classified documents

hotspot

focus

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Pharma budget tightening trickles down to Doximity

Medical leaders decry Supreme Court decision on affirmative action

Gut bacteria may contribute to kidney autoimmunity, study finds

As demand for Covid shots wanes, Moderna seeks its next success

Some of the ways extreme heat will change life as we know it

How one medical school became remarkably diverse

Newly revealed memo details efforts to keep Trump in power following election loss

Medicare proposal to cover medical devices draws a mixed reaction

Timeline: Special counsel's investigation into Trump's handling of classified documents

focus

Bird flu in dairy cattle: New measures to control spread to humans

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Alzheimer's risk factor APOE4 may be a distinct form of the disease

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Alzheimer's risk factor APOE4 may be a distinct form of the disease

U.K. decision on ALS drug has neurologists, advocates up in arms

Wikipedia

explore

Wikipedia

focus